ME

23andMe Holding Co. ME

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ME IDXX TWST GH DMTK A TMO NVTA DHR
6M -83.20 % 45.28 % -18.66 % 95.66 % -92.71 % 33.25 % 29.64 % -97.66 % 7.88 %
YTD -82.92 % 53.73 % -31.21 % 190.87 % -94.34 % 7.46 % 6.43 % -96.90 % -6.43 %
1Y -94.07 % 39.34 % -27.81 % 300.56 % -97.12 % 9.04 % 1.01 % -98.64 % -11.26 %
3Y -98.90 % 74.75 % -5.06 % 86.69 % -99.72 % 3.64 % 8.21 % -99.96 % -3.60 %
5Y -99.69 % 47.95 % -59.33 % -13.36 % -99.55 % 40.44 % 17.55 % -99.92 % 5.69 %
10Y -99.69 % 815.97 % 122.64 % 186.99 % -99.52 % 279.71 % 325.26 % -99.89 % 243.02 %
From the beginning -99.69 % 132 879.31 % 122.64 % 186.99 % -99.52 % 397.85 % 44 039.68 % -99.89 % 35 998.10 %

Dividend

Agilent Technologies, Inc.

Thermo Fisher Scientific Inc.

Danaher Corporation